Cargando…
3-Hydroxyisobutyryl-CoA Hydrolase (HIBCH) Deficiency Cases Diagnosed by Only HIBCH Gene Analysis and Novel Pathogenic Mutation
OBJECTIVE: 3-Hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency is a rare metabolic disease of valine metabolism. Only 22 cases of HIBCH deficiency have been reported in the literature. Our algorithm could help in the diagnosis of this disease. METHODS: HIBCH gene analysis was performed in all cases...
Autores principales: | Çakar, Nafiye Emel, Görükmez, Orhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370149/ https://www.ncbi.nlm.nih.gov/pubmed/34447000 http://dx.doi.org/10.4103/aian.AIAN_192_20 |
Ejemplares similares
-
MRI of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency
por: Casano, Kelsey R., et al.
Publicado: (2021) -
3‐Hydroxyisobutyryl‐CoA hydrolase deficiency in an Iranian child with novel HIBCH compound heterozygous mutations
por: Karimzadeh, Parvaneh, et al.
Publicado: (2019) -
Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis
por: Yamada, Kenichiro, et al.
Publicado: (2014) -
Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer
por: Shan, Yunlong, et al.
Publicado: (2019) -
Leigh-like syndrome with progressive cerebellar atrophy caused by novel HIBCH variants
por: Taura, Yoshihiro, et al.
Publicado: (2023)